Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,149,450 | 8,659,600 | 6,632,050 | 9,462,750 | 9,650,450 |
| Marketable Securities | 354,340 | 345,820 | 206,060 | 0 | 0 |
| Receivables | 7,808,690 | 8,717,500 | 8,309,090 | 8,946,130 | 8,957,710 |
| Inventories | 6,973,110 | 6,102,720 | 6,291,260 | 6,213,840 | 5,933,150 |
| Other current assets | 1,905,220 | 1,560 | 264,720 | 1,315,610 | 255,150 |
| TOTAL | $24,190,810 | $23,827,200 | $21,703,180 | $25,938,330 | $24,796,460 |
| Non-Current Assets | |||||
| PPE Net | 14,918,600 | 13,882,900 | 13,910,830 | 14,035,290 | 14,083,700 |
| Investments And Advances | 2,396,330 | 2,387,880 | 2,250,840 | 1,845,060 | 2,770,960 |
| Other Non-Current Assets | 25,491,150 | 25,758,160 | 27,877,140 | 24,090,050 | 23,373,860 |
| TOTAL | $42,806,080 | $42,028,940 | $44,038,810 | $39,970,400 | $40,228,520 |
| Total Assets | $66,996,910 | $65,856,170 | $65,742,020 | $65,908,750 | $65,025,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,115,570 | 13,014,440 | 12,766,390 | 11,806,770 | 10,650,910 |
| Accrued Expenses | 1,557,450 | 2,272,080 | 2,177,920 | 2,636,020 | 1,343,730 |
| Other current liabilities | 2,388,090 | 1,751,010 | 1,198,330 | 5,310,560 | 7,063,490 |
| TOTAL | $21,911,480 | $21,401,760 | $21,898,150 | $24,082,040 | $19,508,120 |
| Non-Current Liabilities | |||||
| Long Term Debt | 26,107,550 | 24,185,540 | 23,255,000 | 19,578,490 | 22,899,150 |
| Other Non-Current Liabilities | 10,109,440 | 6,960,230 | 8,302,750 | 6,767,350 | 6,455,800 |
| TOTAL | $36,950,390 | $32,230,170 | $33,149,190 | $27,664,650 | $30,448,180 |
| Total Liabilities | $58,861,890 | $53,631,950 | $55,047,350 | $51,746,710 | $49,956,310 |
| Shareholders' Equity | |||||
| Common Shares | 2,206,800 | 2,090,570 | 2,138,290 | 2,225,300 | 2,192,650 |
| Retained earnings | -3,418,150 | 1,428,660 | 1,033,480 | 5,406,820 | 7,389,760 |
| Other shareholders' equity | 4,799,270 | 4,644,330 | 4,317,820 | 3,845,750 | 3,278,170 |
| TOTAL | $8,135,020 | $12,224,210 | $10,694,660 | $14,162,030 | $15,068,690 |
| Total Liabilities And Equity | $66,996,910 | $65,856,160 | $65,742,010 | $65,908,740 | $65,025,000 |